Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Stroke ; 42(10): 2832-7, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21852622

ABSTRACT

BACKGROUND AND PURPOSE: Although conceivably relevant for penumbra oxygenation, the optimal levels of hemoglobin (Hb) and hematocrit (Hct) in patients with acute ischemic stroke are unknown. METHODS: We identified patients from our prospective local stroke database who received intravenous thrombolysis based on multimodal magnet resonance imaging during the years 1998 to 2009. A favorable outcome at 3 months was defined as a modified Rankin Scale score≤2 and a poor outcome as a modified Rankin Scale score≥3. The dynamics of Hemoglobin (Hb), Hematocrit (Hct), and other relevant laboratory parameters as well as cardiovascular risk factors were retrospectively assessed and analyzed between these 2 groups. RESULTS: Of 217 patients, 114 had a favorable and 103 a poor outcome. In a multivariable regression model, anemia until day 5 after admission (odds ratio [OR]=2.61; 95% CI, 1.33 to 5.11; P=0.005), Hb nadir (OR=0.81; 95% CI, 0.67 to 0.99; P=0.038), and Hct nadir (OR=0.93; 95% CI, 0.87 to 0.99; P=0.038) remained independent predictors for poor outcome at 3 months. Mortality after 3 months was independently associated with Hb nadir (OR=0.80; 95% CI, 0.65 to 0.98; P=0.028) and Hb decrease (OR=1.34; 95% CI, 1.01 to 1.76; P=0.04) as well as Hct decrease (OR=1.12; 95% CI, 1.01 to 1.23; P=0.027). CONCLUSIONS: Poor outcome and mortality after ischemic stroke are strongly associated with low and further decreasing Hb and Hct levels. This decrease of Hb and Hct levels after admission might be more relevant and accessible to treatment than are baseline levels.


Subject(s)
Brain Ischemia/blood , Hemoglobins/metabolism , Stroke/blood , Aged , Aged, 80 and over , Brain Ischemia/drug therapy , Brain Ischemia/mortality , Databases, Factual , Female , Fibrinolytic Agents/therapeutic use , Hematocrit , Humans , Male , Middle Aged , Predictive Value of Tests , Prognosis , Stroke/drug therapy , Stroke/mortality , Tissue Plasminogen Activator/therapeutic use , Treatment Outcome
2.
J Clin Endocrinol Metab ; 89(6): 3048-54, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15181097

ABSTRACT

Ghrelin is an orexigenic gastric hormone that decreases in peripheral blood after carbohydrate-rich meals but increases after protein ingestion. In the present study plasma ghrelin was determined together with hunger and satiety ratings and with insulin and glucose concentrations after the ingestion of satiating quantities of carbohydrate-, fat-, protein-, fruit-, and vegetable-rich meals in 14 healthy subjects. Four hours later, standardized sandwiches were consumed. After carbohydrate, ghrelin decreased, whereas fat, protein, fruit, and vegetable ingestion significantly increased ghrelin levels. Considering all test meals, no significant correlation existed between changes of ghrelin levels and satiety ratings (r = 0.05; not significant), whereas a significant inverse relationship was observed between plasma ghrelin and insulin levels (r = -0.44; P < 0.001). During the second meal, sandwich consumption was significantly greater after the preceding fruit and vegetable meals, which was significantly correlated with the fourth-hour increase of ghrelin (r = 0.44; P < 0.001). In conclusion, after an overnight fast, ghrelin release depends on the ingested macronutrients and is most likely not a major regulator of acute food intake, although it is of greater importance for the recurrence of hunger and subsequent meal size.


Subject(s)
Blood Glucose/metabolism , Eating/physiology , Insulin/blood , Peptide Hormones/blood , Satiety Response/physiology , Adult , Dietary Carbohydrates/administration & dosage , Dietary Proteins/administration & dosage , Energy Metabolism/physiology , Female , Fruit , Ghrelin , Humans , Hunger/physiology , Male , Postprandial Period/physiology , Vegetables
SELECTION OF CITATIONS
SEARCH DETAIL
...